Surgical excision versus Mohs micrographic surgery for primary and recurrent basal cell carcinoma of the face

ISRCTN ISRCTN65009900
DOI https://doi.org/10.1186/ISRCTN65009900
Protocol serial number OG 99-030
Sponsor The Netherlands Organisation for Health Research and Development (ZonMw) (The Netherlands)
Funder The Netherlands Organisation for Health Research and Development (ZonMw) (The Netherlands) (ref: OG 99-30)
Submission date
15/10/2008
Registration date
27/10/2008
Last edited
21/01/2015
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Cancer
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Nicole Kelleners-Smeets
Scientific

P. Debyelaan 25
Maastricht
6202 AZ
Netherlands

Email n.kelleners.smeets@mumc.nl

Study information

Primary study designInterventional
Study designRandomised controlled multicentre trial
Secondary study designRandomised controlled trial
Study type Participant information sheet
Scientific titleExamining the (cost-) effectiveness of Mohs micrographic surgery versus surgical excision in the treatment of primary and recurrent basal cell carcinoma: a prospective randomised study
Study acronymMP
Study objectivesMohs micrographic surgery (MMS) is superior to surgical excision in recurrence rate.
Ethics approval(s)Medical Ethics Committee of the Maastricht University on the 20th October 1999
Health condition(s) or problem(s) studiedPrimary or first or second recurrent basal cell carcinoma
InterventionArm 1: Mohs micrographic surgery -
Tumours were excised with a margin of 3 mm under an angle of 45 degrees. The complete resection margins of the excised material were investigated histopathologically on horizontal frozen section slides. In case of positive resection margins, the procedure was repeated, until total clearance was obtained. The duration of the procedure was dependent of the number of mohs stages. Primary and secondary outcome measures were measured after 5 years follow-up.

Arm 2: surgical excision -
Tumours were excised with a margin of 3 mm under an angle of 90 degrees. The histolopathological examination was performed on vertical slides. The duration of the procedure was approximately 45 minutes per treatment. Primary and secondary outcome measures were measured after 5 years follow-up.
Intervention typeOther
Primary outcome measure(s)

Recurrence of carcinoma after 5 years follow-up

Key secondary outcome measure(s)

1. Determinants of failure after 5 years of follow-up, tested with Cox regression analysis
2. Cost-effectiveness after 5 years of follow-up an incremental cost-effectiveness ratio was calculated, all personal and material costs of both treatments that have been made during procedures and follow-up were calculated by multiplying volumes of use with the cost per unit

Completion date01/02/2007

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexAll
Target sample size at registration612
Key inclusion criteria1. Primary or first or second recurrent basal cell carcinoma
2. Aged 18 years or older, either sex
Key exclusion criteriaExpected life-duration of less than 3 years
Date of first enrolment01/11/1999
Date of final enrolment01/02/2007

Locations

Countries of recruitment

  • Netherlands

Study participating centre

P. Debyelaan 25
Maastricht
6202 AZ
Netherlands

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results: 01/11/2004 Yes No
Results article results 01/11/2014 Yes No
Participant information sheet Participant information sheet 11/11/2025 11/11/2025 No Yes